会员体验
专利管家(专利管理)
工作空间(专利管理)
风险监控(情报监控)
数据分析(专利分析)
侵权分析(诉讼无效)
联系我们
交流群
官方交流:
QQ群: 891211   
微信请扫码    >>>
现在联系顾问~
热词
    • 3. 发明公开
    • CHEMICAL PRODUCTION MODULE AND DOSE SYNTHESIS CARD FOR PET BIOMARKER PRODUCTION SYSTEM
    • CHEMISCHES PRODUKTIONSMODUL UNDISISYYTHESEKARTEFÜREIN HAUSTIER-BIOMARKER-PRODUKTIONSSYSTEM
    • EP2480258A4
    • 2017-03-22
    • EP10819146
    • 2010-09-21
    • ABT MOLECULAR IMAGING INC
    • NUTT RONALDGIAMIS ANTHONY MMCFARLAND AARON
    • A61K51/00A61M3/00A61M36/14B01J19/00
    • A61K51/0491B01J19/004B01J19/0093B01J2219/00788B01J2219/00873B01J2219/00891B01J2219/00905
    • A microfluidic radiopharmaceutical production system and process for synthesizing per run approximately, but not less than, one (1) unit dose of a radiopharmaceutical biomarker for use in positron emission tomography (PET). The radiopharmaceutical production system includes a reaction vessel that receives a radioisotope from an accelerator or other radioisotope generator. Organic and aqueous reagents are introduced into the reaction vessel, and the mixture is heated to synthesize a solution of a pre-selected radiopharmaceutical. The radiopharmaceutical solution is purified by passing the solution through a solid phase extraction column and a filter. The synthesis process produces per run a quantity of radiopharmaceutical approximately equal to, but not less than, one (1) unit dose of a radiopharmaceutical, reducing waste and allowing for the production of radiopharmaceutical on an as-needed basis. The synthesis process allows for the production of biomarker radiopharmaceuticals on site and close to the location where the unit dose will be administered to the patient. On-site, as-needed production of radiopharmaceuticals in small doses reduces the time between the synthesis of the radiopharmaceutical and the administration of that radiopharmaceutical, thereby minimizing the loss of active isotopes through decay and allowing the production of lesser amounts of radioisotopes overall.
    • 一种微流体放射性药物生产系统和用于在正电子发射断层摄影(PET)中使用的放射性药物生物标志物的大约一个但不少于一个单位剂量的合成的方法。 放射性药物生产系统包括从加速器或其它放射性同位素发生器接收放射性同位素的反应容器。 将有机和水性试剂引入反应容器中,并加热混合物以合成预先选择的放射性药物的溶液。 通过使溶液通过固相萃取柱和过滤器来纯化放射性药物溶液。 合成过程每次运行一定量的放射性药物,大约等于但不小于一(1)个单位剂量的放射性药物,减少浪费并允许根据需要生产放射性药物。 合成过程允许在现场生产标记放射性药物并且靠近给予患者的单位剂量的位置。 现场按需要以小剂量生产放射性药物可以减少放射性药物的合成和放射性药物的施用之间的时间,从而通过衰变最大程度地减少活性同位素的损失,并允许总体生产较少量的放射性同位素。
    • 7. 发明公开
    • VORRICHTUNG UND VERFAHREN ZUR HERSTELLUNG RADIOCHEMISCHER VERBINDUNGEN
    • EP2585211A2
    • 2013-05-01
    • EP11828159.1
    • 2011-06-20
    • ABX Advanced Biochemical Compounds GmbHGeSIM Gesellschaft für Silizium-Mikrosysteme mbH
    • MÜLLER, MarcoHOWITZ, Steffen
    • B01J19/00C07B59/00
    • C07B59/005B01J19/004B01J19/0046B01J19/0093B01J2219/00038B01J2219/0004B01J2219/00094B01J2219/00132B01J2219/00141B01J2219/00283B01J2219/00333B01J2219/00364B01J2219/00585B01J2219/00599B01J2219/00704B01J2219/0072B01J2219/00731B01J2219/00788B01J2219/0081B01J2219/00882B01J2219/00889B01J2219/00916B01J2219/00941C07B59/00C07B2200/05C07H5/02
    • The invention relates to a device for producing radiochemical compounds. Said device comprises at least a reaction module, a dosing module, and a supply module. The reaction module has at least one reaction vessel that includes a closeable opening through which substances needed for the production of a predefined radiochemical compound can be introduced into the reaction vessel of the reaction module and through which the produced radiochemical compound can be removed from the reaction vessel of the reaction module. The dosing module has at least one pipetting head which can be moved relative to the supply module and the reaction module in the x, y, and z directions and also has at least one dosing unit. At least one storage tank for one of the substances needed for the production of the respective radiochemical substance is formed in the supply module.
    • 该装置包括反应模块(2),计量模块,供应模块和分配模块,其中反应模块包括具有可闭合的开口的反应容器(3),通过该开闭开口将产生预定放射化学化合物所需的物质引入 反应容器。 将产生的放射化学化合物从反应模块的反应容器中除去。 给药模块包括移液头(9),其相对移动到供应和反应模块并且包括剂量单位(10a,10b,10c,12)。 该装置包括反应模块(2),计量模块,供应模块和分配模块,其中反应模块包括具有可闭合的开口的反应容器(3),通过该开闭开口将产生预定放射化学化合物所需的物质引入 反应容器。 将产生的放射化学化合物从反应模块的反应容器中除去。 给药模块包括移液头(9),其相对移动到供应和反应模块并且包括剂量单位(10a,10b,10c,12)。 在供给模块中形成有用于制备各放射化学化合物的储存器。 反应模块的反应容器的内部容积为10n至20.000ml。 反应模块包括加热和/或冷却装置和/或微波。 反应容器包括封闭物,当将产生各种放射化学化合物所需的物质引入反应容器或将反应混合物或反应混合物的一部分从反应容器中排出时,封闭物打开。 在确定物质的供应或清除后,开口关闭。 当将产生各种放射化学化合物所需的物质引入反应容器或反应混合物或反应混合物的一部分从反应容器中散出时,剂量单位封闭开口。 移液头可在x,y方向或x,y和z方向上移动。 该装置包括剂量单元,其从供应模块中除去粉末状物质以运输反应模块,并且经由开口将粉末状物质引入反应容器,和/或另外的剂量单元将液体物质从供给模块中除去 运输反应模块,并通过开口将液体物质引入反应容器。 剂量单元包括用于从反应容器供应和除去液体和气体物质的通道(23)。 包括用于使用装置生产放射化学化合物的方法的独立权利要求。
    • 8. 发明公开
    • Catalytic reaction process using microchannel technology
    • Katalysator-Reaktionsverfahren unter Verwendung der Mikrokanal-Technologie
    • EP2543434A1
    • 2013-01-09
    • EP12153890.4
    • 2006-06-30
    • Velocys Inc.
    • Tonkovich, Anna LeeJarosch, Kai Tod PaulSullivan, Timothy J.Mazanec, TerryFitzgerald, Sean PatrickFanelli, Maddalena
    • B01J19/00B01J23/889C10G2/00
    • B01J23/8896B01J19/0093B01J35/023B01J2219/00783B01J2219/00788B01J2219/00835B01J2219/00873B01J2219/00889B01J2219/00984C10G2/32C10G2/33C10G29/205C10G45/02C10G47/02C10G50/00C10G2300/301C10G2300/302C10G2300/4018C10G2300/4025C10G2300/802C10G2300/805C10G2300/807C10G2400/04C10G2400/10C10L1/08
    • The disclosed technology relates to a process for conducting a chemical reaction between at least one liquid reactant and at least one gaseous reactant in a process microchannel containing at least one catalyst, the catalyst comprising a solid phase catalyst or a homogeneous catalyst immobilized on a solid. In one embodiment, the process microchannel comprises a processing zone containing one or more structures for disrupting fluid flow and a reaction zone containing one or more structures for contacting and/or supporting the catalyst, the one or more structures for contacting and/or supporting the catalyst containing openings to permit the reactants to flow through the one or more structures and contact the catalyst. The process comprises: forming a reactant mixture comprising at least one liquid reactant and the at least one gaseous reactant; flowing the reactant mixture in the processing zone in contact with the one or more structures for disrupting fluid flow to enhance mixing of the liquid reactant and the gaseous reactant; flowing the reactant mixture in openings in the one or more structures for contacting and/or supporting the catalyst in contact with catalyst; and reacting the at least one liquid reactant with the at least one gaseous reactant to form at least one product. In one embodiment, the process relates to a process for conducting a Fischer-Tropsch synthesis in a process microchannel containing at least one Fischer-Tropsch synthesis catalyst, the catalyst comprising a solid phase catalyst or a homogeneous catalyst immobilized on a solid, the process comprising: flowing reactants comprising H 2 and CO in the process microchannel, the inlet superficial velocity of the reactants being at least about 0.1 m/s; contacting the Fischer-Tropsch synthesis catalyst with the reactants; and reacting the reactants in the presence of the catalyst to form at least one product.
    • 所公开的技术涉及在含有至少一种催化剂的工艺微通道中的至少一种液体反应物与至少一种气体反应物之间进行化学反应的方法,所述催化剂包含固相催化剂或固相在固体上的均相催化剂。 在一个实施方案中,工艺微通道包括含有用于破坏流体流动的一种或多种结构的处理区和含有用于接触和/或支撑催化剂的一种或多种结构的反应区,用于接触和/或支撑催化剂的一种或多种结构 催化剂含有开口以允许反应物流过一个或多个结构并与催化剂接触。 该方法包括:形成包含至少一种液体反应物和至少一种气态反应物的反应物混合物; 使处理区中的反应物混合物与一个或多个结构接触以破坏流体流动,以增强液体反应物和气态反应物的混合; 使反应物混合物在一个或多个结构中的开口中流动,用于接触和/或支撑与催化剂接触的催化剂; 以及使所述至少一种液体反应物与所述至少一种气体反应物反应以形成至少一种产物。 在一个实施方案中,该方法涉及在含有至少一种费 - 托合成催化剂的工艺微通道中进行费 - 托合成的方法,该催化剂包含固相在固体上的固相催化剂或均相催化剂,该方法包括 :在工艺微通道中包含H 2和CO的流动反应物,反应物的入口空塔速度为至少约0.1m / s; 使费 - 托合成催化剂与反应物接触; 并在催化剂存在下使反应物反应以形成至少一种产物。